Author pages are created from data sourced from our academic publisher partnerships and public sources.
Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
OBJECTIVES There are numerous reports describing the use of radiofrequency ablation (RFA) to treat renal cell carcinoma. Many series, however, describe heterogeneous populations, lack histologic… Expand
FDG PET/CT and MRI Features of Pathologically Proven Schwannomas.
PURPOSE The aim of this study was to examine the MRI and FDG PET/CT imaging features of pathologically proven schwannomas. PATIENTS AND METHODS This institutional review board-approved… Expand
Cancer-free survival after impendence-based radiofrequency ablation of biopsy proven renal cell carcinomas: minimum one year follow-up
Purpose As new ablation technologies evolve, RFA of renal cell carcinoma (RCCa) may provide durable cancer free survival. Many reported series lack histologic confirmation of malignancy, use various… Expand